Public Profile

Chengdu Kanghong Pharmaceutical Group Co., Ltd

Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in the development and production of innovative medical products, particularly in the fields of ophthalmology and oncology. Kanghong's core offerings include a range of high-quality pharmaceuticals and medical devices, distinguished by their commitment to research and development. The company has achieved notable market recognition, positioning itself as a trusted provider in both domestic and international markets. With a focus on enhancing patient care, Kanghong continues to expand its operational footprint, contributing to advancements in healthcare solutions.

DitchCarbon Score

How does Chengdu Kanghong Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Chengdu Kanghong Pharmaceutical Group Co., Ltd's score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

11%

Chengdu Kanghong Pharmaceutical Group Co., Ltd's reported carbon emissions

Chengdu Kanghong Pharmaceutical Group Co., Ltd, headquartered in China, currently does not have publicly available data regarding its carbon emissions. As such, there are no specific figures to report on their Scope 1, 2, or 3 emissions. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, which limits the ability to assess their environmental impact or sustainability efforts. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. However, without concrete data or commitments, it is challenging to evaluate Chengdu Kanghong Pharmaceutical Group's position on climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chengdu Kanghong Pharmaceutical Group Co., Ltd's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Chengdu Kanghong Pharmaceutical Group Co., Ltd is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chengdu Kanghong Pharmaceutical Group Co., Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Novartis

CH
Chemicals nec
Updated 1 day ago

Alimera Sciences, Inc.

US
Chemicals nec
Updated 2 months ago
DitchCarbon Score

Allergan

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Genentech

US
Research and development services (73)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers